These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 18455873)
1. Reduced expression of glyoxalase-1 mRNA in mood disorder patients. Fujimoto M; Uchida S; Watanuki T; Wakabayashi Y; Otsuki K; Matsubara T; Suetsugi M; Funato H; Watanabe Y Neurosci Lett; 2008 Jun; 438(2):196-9. PubMed ID: 18455873 [TBL] [Abstract][Full Text] [Related]
2. Reduced Glucocorticoid Receptor alpha Expression in Mood Disorder Patients and First-Degree Relatives. Matsubara T; Funato H; Kobayashi A; Nobumoto M; Watanabe Y Biol Psychiatry; 2006 Apr; 59(8):689-95. PubMed ID: 16458268 [TBL] [Abstract][Full Text] [Related]
3. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders. Wakabayashi Y; Uchida S; Funato H; Matsubara T; Watanuki T; Otsuki K; Fujimoto M; Nishida A; Watanabe Y Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1199-205. PubMed ID: 18430502 [TBL] [Abstract][Full Text] [Related]
9. Methylglyoxal-mediated anxiolysis involves increased protein modification and elevated expression of glyoxalase 1 in the brain. Hambsch B; Chen BG; Brenndörfer J; Meyer M; Avrabos C; Maccarrone G; Liu RH; Eder M; Turck CW; Landgraf R J Neurochem; 2010 Jun; 113(5):1240-51. PubMed ID: 20345757 [TBL] [Abstract][Full Text] [Related]
10. State-dependent changes in the expression of DNA methyltransferases in mood disorder patients. Higuchi F; Uchida S; Yamagata H; Otsuki K; Hobara T; Abe N; Shibata T; Watanabe Y J Psychiatr Res; 2011 Oct; 45(10):1295-300. PubMed ID: 21592522 [TBL] [Abstract][Full Text] [Related]
11. Glyoxalase-I mRNA expression and CCK-4 induced panic attacks. Eser D; Uhr M; Leicht G; Asmus M; Länger A; Schüle C; Baghai TC; Mulert C; Rupprecht R J Psychiatr Res; 2011 Jan; 45(1):60-3. PubMed ID: 20542521 [TBL] [Abstract][Full Text] [Related]
12. [Functional biomarkers of mood disorders: differential diagnosis and clinical classification with gene expression in peripheral leukocytes]. Watanabe Y; Uchida S; Otsuki K; Yamagata H; Hobara T; Abe N; Higuchi F; Watanuki T; Matsubara T Seishin Shinkeigaku Zasshi; 2012; 114(7):812-20. PubMed ID: 22897028 [TBL] [Abstract][Full Text] [Related]
13. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Webster MJ; Knable MB; O'Grady J; Orthmann J; Weickert CS Mol Psychiatry; 2002; 7(9):985-94, 924. PubMed ID: 12399952 [TBL] [Abstract][Full Text] [Related]
14. Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders. Su TP; Zhang L; Chung MY; Chen YS; Bi YM; Chou YH; Barker JL; Barrett JE; Maric D; Li XX; Li H; Webster MJ; Benedek D; Carlton JR; Ursano R J Psychiatr Res; 2009 Sep; 43(13):1078-85. PubMed ID: 19380152 [TBL] [Abstract][Full Text] [Related]
15. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. Thompson M; Weickert CS; Wyatt E; Webster MJ J Psychiatr Res; 2009 Jul; 43(11):970-7. PubMed ID: 19321177 [TBL] [Abstract][Full Text] [Related]
16. Gene and expression analyses reveal enhanced expression of pericentrin 2 (PCNT2) in bipolar disorder. Anitha A; Nakamura K; Yamada K; Iwayama Y; Toyota T; Takei N; Iwata Y; Suzuki K; Sekine Y; Matsuzaki H; Kawai M; Miyoshi K; Katayama T; Matsuzaki S; Baba K; Honda A; Hattori T; Shimizu S; Kumamoto N; Tohyama M; Yoshikawa T; Mori N Biol Psychiatry; 2008 Apr; 63(7):678-85. PubMed ID: 17884020 [TBL] [Abstract][Full Text] [Related]
17. Gene expression and association analysis of LIM (PDLIM5) in major depression. Iga J; Ueno S; Yamauchi K; Numata S; Motoki I; Tayoshi S; Kinouchi S; Ohta K; Song H; Morita K; Rokutan K; Tanabe H; Sano A; Ohmori T Neurosci Lett; 2006 Jun; 400(3):203-7. PubMed ID: 16595163 [TBL] [Abstract][Full Text] [Related]
18. The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders. Kurt E; Guler O; Serteser M; Cansel N; Ozbulut O; Altinbaş K; Alataş G; Savaş H; Gecici O Neurosci Lett; 2007 Oct; 426(1):49-53. PubMed ID: 17884293 [TBL] [Abstract][Full Text] [Related]